Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Anaesthesist ; 56(10): 1024-7, 2007 Oct.
Article in German | MEDLINE | ID: mdl-17694290

ABSTRACT

Angioneurotic orolingual edema associated with the use of rt-PA (recombinant tissue plasminogen activator) for systemic thrombolysis are described in the literature, but only as isolated case reports. Strangely, the rate of anaphylactic reactions to rt-PA is higher (1.9%) when they are used in the treatment of acute stroke than when they are given to treat acute myocardial infarction (0.02%). Patients who are taking ACE inhibitors seem to be at increased risk of such a potentially life-threatening event. We now report on two patients, in each of whom asymmetric angioneurotic edema was observed following successful thrombolysis with rt-PA. Both these patients were taking ACE inhibitors. It was possible to avoid intubation and ventilation in both cases. Therapy with ranitidine, clemastine, and a C1 esterase inhibitor resulted in the resolution of symptomatic angioneurotic edema within hours.


Subject(s)
Angioedema/chemically induced , Edema/chemically induced , Fibrinolytic Agents/adverse effects , Tissue Plasminogen Activator/adverse effects , Tongue Diseases/chemically induced , Angioedema/pathology , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Clemastine/therapeutic use , Complement C1s/antagonists & inhibitors , Edema/pathology , Female , Fibrinolytic Agents/therapeutic use , Histamine H1 Antagonists/therapeutic use , Histamine H2 Antagonists/therapeutic use , Humans , Middle Aged , Neurologic Examination , Ranitidine/therapeutic use , Recombinant Proteins/adverse effects , Stroke/complications , Stroke/drug therapy , Tissue Plasminogen Activator/therapeutic use , Tongue Diseases/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...